2018
DOI: 10.1016/j.cryobiol.2018.02.008
|View full text |Cite
|
Sign up to set email alerts
|

Fetal bovine serum-free cryopreservation methods for clinical banking of human adipose-derived stem cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(16 citation statements)
references
References 35 publications
0
15
0
1
Order By: Relevance
“…One concern is the use of FBS either as a bioink or as cryoprotectant supplement since it introduces the risk of immunological rejection and the transmission of diseases. The alternative is the use of xeno-free cryoprotectant supplements [51,52]. Moreover, for the implementation of autologous cell therapies, there is still the need for primary cell extraction and expansion, making more challenging the treatment of bone injuries that require immediate attention.…”
Section: Discussionmentioning
confidence: 99%
“…One concern is the use of FBS either as a bioink or as cryoprotectant supplement since it introduces the risk of immunological rejection and the transmission of diseases. The alternative is the use of xeno-free cryoprotectant supplements [51,52]. Moreover, for the implementation of autologous cell therapies, there is still the need for primary cell extraction and expansion, making more challenging the treatment of bone injuries that require immediate attention.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, like all adult cell types, ASCs also significantly decrease cell growth after a limited number of in vitro passages due to a cellular process termed replicative senescence. Nowadays, standard protocols for ASC seeding are lacking, as evidenced by the wide range of cellular concentrations (cell density/cm 2 ) used for replating [ 20 , 27 , 28 , 29 ].…”
Section: Culture and Expansion Of Ascsmentioning
confidence: 99%
“…To avoid FBS use, the addition to cryopreservation medium of different supplements such as human serum albumin (9%), human serum (90%) or knockout serum replacement (90%) to maintain the ASC recovery rate, viability, and growth kinetics at level similar to the conventional medium with 90% FBS, has been recently reported [ 29 ]. Gene expression, immunophenotype and multi-lineage differentiation ability of ASCs are not influenced by the different used cryopreservation media.…”
Section: Svf/asc Cryopreservationmentioning
confidence: 99%
See 1 more Smart Citation
“…Indeed, it is well known that this approach is not suitable for clinical use of ASCs or their secretome, due to the risk of transmission of disease as well as xenogeneic immune reactions in the transplanted host [33,86]. In this regard, recently, human serum albumin (HSA), human serum (HS), or knockout serum replacement (KSR) have been suggested as useful replacements of FBS for ASC cryopreservation and clinical banking [87]. It is therefore essential to carry out studies using a human serum or synthetic supplementation, which could also be certified for good manufacturing practice (GMP) use of ASCs or their secretome for wound healing.…”
Section: Discussionmentioning
confidence: 99%